Advances in the treatment of refractory mycoplasma pneumoniae pneumonia in children with different doses of glucocorticoids
10.3760/cma.j.issn.1673-4408.2020.11.010
- VernacularTitle:不同剂量糖皮质激素治疗小儿难治性肺炎支原体肺炎的研究进展
- Author:
Zhenli ZHU
1
;
Yaoyao LING
;
Yongsheng XU
Author Information
1. 天津医科大学研究生院 300070
- From:
International Journal of Pediatrics
2020;47(11):792-795
- CountryChina
- Language:Chinese
-
Abstract:
Mycoplasma pneumoniae is one of the most common pathogens in children with community-acquired pneumonia.Some cases of mycoplasma pneumoniae pneumonia may develop into refractory mycoplasma pneumoniae pneumonia(RMPP). Glucocorticoid therapy can delay the disease and shorten the hospital stay, which is an effective method for the treatment of children with RMPP.This paper reviews the progress of glucocorticoids in the treatment of RMPP in children.
